Hydroxychloroquinsulfat Dr. Eberth

Hydroxychloroquine sulfate, the active ingredient in Hydroxychloroquinsulfat Dr. Eberth, is an antimalarial presented as an oral tablet for oral use. It is employed in the treatment and management of malaria, rheumatoid arthritis, and systemic lupus erythematosus in adult patients. It is often prescribed by rheumatologists and infectious disease specialists.

GNH USA supplies Hydroxychloroquinsulfat Dr. Eberth as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured batches, reliable logistics and support for regulatory documentation across markets.

Hydroxychloroquine sulfate acts on malaria parasites and modulates immune activity in autoimmune diseases. - Malaria: Clears blood‑stage parasites and reduces disease recurrence. - Rheumatoid arthritis: Decreases joint inflammation and slows disease progression. - Systemic lupus erythematosus: Lowers disease activity and prevents flares.

Hydroxychloroquine sulfate may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Nausea: Upset stomach or vomiting. - Headache: Mild to moderate cranial pain. - Dizziness: Light‑headed sensation. - Skin rash: Itchy erythematous eruptions. Serious or Rare Side Effects: - Retinopathy: Progressive vision loss that may be irreversible. - Cardiomyopathy: Heart muscle dysfunction leading to arrhythmias. - Stevens‑Johnson syndrome: Severe skin and mucous membrane reaction.

When prescribing hydroxychloroquine sulfate, several precautions should be observed to minimise risk. - Pregnancy: Use only if potential benefit justifies potential fetal risk. - Retinal monitoring: Perform baseline and periodic ophthalmologic examinations. - Cardiac assessment: Evaluate QT interval and monitor for arrhythmias in at‑risk patients. - Drug interactions: Review concomitant medications that may prolong QT or affect metabolism. - Renal/hepatic impairment: Adjust dosage or monitor closely in patients with organ dysfunction. - Store at ambient temperature: Keep in original packaging, protect from moisture and light.

Hydroxychloroquine sulfate interacts with several medicines; awareness of the interaction level guides clinical management. Major Interactions (Avoid): - Azithromycin: Combined use may markedly prolong QT interval. - Quinine: Additive cardiotoxic effects increase risk of arrhythmia. - Amiodarone: Heightened potential for serious cardiac rhythm disturbances. Moderate Interactions (Monitor Closely): - Cimetidine: May increase hydroxychloroquine plasma concentrations. - Warfarin: Hydroxychloroquine can enhance anticoagulant effect, requiring INR monitoring. - Sulfonylurea antidiabetics: Increased risk of hypoglycaemia; glucose levels should be checked.